|
| Status |
Public on Dec 22, 2020 |
| Title |
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
33490904 |
| |
| Submission date |
Jun 01, 2020 |
| Last update date |
Jan 27, 2021 |
| Contact name |
Hongjian Jin |
| E-mail(s) |
hongjian.jin@STJUDE.ORG
|
| Organization name |
St Jude Children's Research Hospital
|
| Department |
Center for Applied Bioinformatics
|
| Street address |
262 Danny Thomas Place
|
| City |
Memphis |
| State/province |
TN |
| ZIP/Postal code |
38015 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
| Samples (21)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE151493 |
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy [ChIP-seq] |
| GSE151514 |
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy [RNA-seq] |
|
| Relations |
| BioProject |
PRJNA636501 |
Less...
More...